DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer

Bibliographic Details
Title: DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer
Authors: Qi Meng, Yun-Xin Lu, Dan-Yun Ruan, Kai Yu, Yan-Xing Chen, Min Xiao, Yun Wang, Ze-Xian Liu, Rui-Hua Xu, Huai-Qiang Ju, Miao-Zhen Qiu
Source: Molecular Therapy: Nucleic Acids, Vol 24, Iss , Pp 695-710 (2021)
Publisher Information: Elsevier, 2021.
Publication Year: 2021
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: DNA methylation, tumor microenvironment, immunotherapy, biomarker, gastric cancer, Therapeutics. Pharmacology, RM1-950
More Details: Growing evidence implies a link between DNA methylation and tumor immunity/immunotherapy. However, the global influence of DNA methylation on the characteristics of the tumor microenvironment and the efficacy of immunotherapy remains to be clarified. In this study, we systematically evaluated the DNA methylation regulator patterns and tumor microenvironment characteristics of 1,619 gastric cancer patients by clustering the gene expression of 20 DNA methylation regulators. Three gastric cancer subtypes that had different DNA methylation modification patterns and distinct tumor microenvironment characteristics were recognized. Then, a DNA methylation score (DMS) was constructed to evaluate DNA methylation modification individually. High DMS was characterized by immune activation status, increased tumor mutation burden, and tumor neoantigens, with a favorable prognosis. Conversely, activation of the stroma and absence of immune cell infiltration were observed in the low DMS group, with relatively poor survival. High DMS was also certified to be correlated with enhanced efficacy of immunotherapy in four immune checkpoint blocking treatment cohorts. In conclusion, the characterization of DNA methylation modification patterns may help to enhance our recognition of the tumor immune microenvironment of gastric cancer and guide more personalized immunotherapy strategies in the future.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2162-2531
Relation: http://www.sciencedirect.com/science/article/pii/S2162253121000950; https://doaj.org/toc/2162-2531
DOI: 10.1016/j.omtn.2021.03.023
Access URL: https://doaj.org/article/e406e01926b84f209905e5f59f87e2ac
Accession Number: edsdoj.406e01926b84f209905e5f59f87e2ac
Database: Directory of Open Access Journals
More Details
ISSN:21622531
DOI:10.1016/j.omtn.2021.03.023
Published in:Molecular Therapy: Nucleic Acids
Language:English